A phase II neoadjuvant trial of concurrent trastuzumab and paclitaxel without anthracycline in women with HER2-positive operable breast cancer.
H. Jinno
No relevant relationships to disclose
T. Hayashida
No relevant relationships to disclose
M. Takahashi
No relevant relationships to disclose
S. Hirose
No relevant relationships to disclose
Y. Kitagawa
No relevant relationships to disclose